(Q46698040)

24 December 2017

review article

1 reference

title

Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome (English)

1 reference

24 December 2017

1 reference

1 reference

Augusto Cézar Santomauro Júnior

1

1 reference

24 December 2017

Michelle Remião Ugolini

2

1 reference

24 December 2017

Ana Teresa Santomauro

3

1 reference

24 December 2017

Ricardo Peres do Souto

4

1 reference

24 December 2017

language of work or name

Portuguese

0 references

publication date

1 February 2008

1 reference

24 December 2017

Arquivos Brasileiros de Endocrinologia e Metabologia

published in

1 reference

24 December 2017

volume

52

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

120-125

1 reference

24 December 2017

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

1 reference

Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Traditional plant medicines as treatments for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Effect of plasma metformin concentrations on serum lipid levels in type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Metformin treatment corrects vascular insulin resistance in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

The AMP-activated protein kinase cascade--a unifying system for energy control

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

AMP-activated protein kinase: Role in metabolism and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

AMP-activated protein kinase and muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000100017

10.1590/S0004-27302008000100017

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18345405

1 reference

24 December 2017